3odk
From Proteopedia
(Difference between revisions)
												
			
			 (New page: '''Unreleased structure'''  The entry 3odk is ON HOLD   Authors: Potter, A., Oldfield, V., Nunns, C., Fromont, C., Ray, S., Northfield, C.J., Bryant, C.J., Scrace, S.F., Robinson, D., Mato...)  | 
				|||
| (9 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure'''  | ||
| - | + | ==Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution==  | |
| + | <StructureSection load='3odk' size='340' side='right'caption='[[3odk]], [[Resolution|resolution]] 2.30Å' scene=''>  | ||
| + | == Structural highlights ==  | ||
| + | <table><tr><td colspan='2'>[[3odk]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ODK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3ODK FirstGlance]. <br>  | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr>  | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ODK:3-PYRIDIN-2-YL-1H-PYRAZOLE-5-CARBOXYLIC+ACID'>ODK</scene>, <scene name='pdbligand=PE4:2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL'>PE4</scene></td></tr>  | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3odk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3odk OCA], [https://pdbe.org/3odk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3odk RCSB], [https://www.ebi.ac.uk/pdbsum/3odk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3odk ProSAT]</span></td></tr>  | ||
| + | </table>  | ||
| + | == Function ==  | ||
| + | [https://www.uniprot.org/uniprot/PIN1_HUMAN PIN1_HUMAN] Essential PPIase that regulates mitosis presumably by interacting with NIMA and attenuating its mitosis-promoting activity. Displays a preference for an acidic residue N-terminal to the isomerized proline bond. Catalyzes pSer/Thr-Pro cis/trans isomerizations. Down-regulates kinase activity of BTK. Can transactivate multiple oncogenes and induce centrosome amplification, chromosome instability and cell transformation. Required for the efficient dephosphorylation and recycling of RAF1 after mitogen activation.<ref>PMID:15664191</ref> <ref>PMID:16644721</ref> <ref>PMID:21497122</ref>   | ||
| - | + | ==See Also==  | |
| - | + | *[[Peptidyl-prolyl cis-trans isomerase 3D structures|Peptidyl-prolyl cis-trans isomerase 3D structures]]  | |
| - | + | == References ==  | |
| - | + | <references/>  | |
| - | + | __TOC__  | |
| + | </StructureSection>  | ||
| + | [[Category: Homo sapiens]]  | ||
| + | [[Category: Large Structures]]  | ||
| + | [[Category: Baker L]]  | ||
| + | [[Category: Bryant CJ]]  | ||
| + | [[Category: Davis BE]]  | ||
| + | [[Category: Dokurno P]]  | ||
| + | [[Category: Fromont C]]  | ||
| + | [[Category: Matossova N]]  | ||
| + | [[Category: Moore JD]]  | ||
| + | [[Category: Murray JB]]  | ||
| + | [[Category: Northfield CJ]]  | ||
| + | [[Category: Nunns C]]  | ||
| + | [[Category: Oldfield V]]  | ||
| + | [[Category: Potter A]]  | ||
| + | [[Category: Ray S]]  | ||
| + | [[Category: Richardson CM]]  | ||
| + | [[Category: Robinson D]]  | ||
| + | [[Category: Scrace SF]]  | ||
| + | [[Category: Surgenor AE]]  | ||
Current revision
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution
  | |||||||||||
Categories: Homo sapiens | Large Structures | Baker L | Bryant CJ | Davis BE | Dokurno P | Fromont C | Matossova N | Moore JD | Murray JB | Northfield CJ | Nunns C | Oldfield V | Potter A | Ray S | Richardson CM | Robinson D | Scrace SF | Surgenor AE
